Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Open Access Maced J Med Sci ; 6(11): 1982-1985, 2018 Nov 25.
Artículo en Inglés | MEDLINE | ID: mdl-30559847

RESUMEN

BACKGROUND: Nasopharyngeal carcinoma (NPC) is uncommon and usually diagnosed at the advanced stage. A subfamily of mitogen-activated protein kinase which is called p38 mitogen-activated protein kinase (MAPK) involved in response to stress, and plays an important role in cell regulation. There is a suggestion that p38 mitogen-activated protein kinase could be a potential biomarker to determine the clinical stage of nasopharyngeal carcinoma. AIM: The aim of this study is for observing and analysing the correlation of p38 mitogen-activated protein kinase expression in regards to nasopharyngeal carcinoma patient's clinical stage. METHODS: This study involved 126 nasopharyngeal carcinoma patients admitted to Haji Adam Malik General Hospital. RESULTS: The result of this study indicates that nasopharyngeal carcinoma mostly found in the age group 41-60 years, male, non-keratinizing squamous cell carcinoma, and stage IV group. In immunohistochemistry evaluation, most of p38 mitogen-activated protein kinase overexpressed in non-keratinizing squamous cell carcinoma, T3-T4, N2-N3 and clinical stage III-IV. Spearman's test for categorical correlation yield p-value of < 0.001. CONCLUSION: In conclusion, there is a significant correlation between p38 mitogen-activated protein kinase expression and the clinical stage of nasopharyngeal carcinoma.

2.
Open Access Maced J Med Sci ; 6(11): 2001-2005, 2018 Nov 25.
Artículo en Inglés | MEDLINE | ID: mdl-30559850

RESUMEN

AIM: This study aimed to observe the cyclooxygenase-2 expression and its correlation with tumour size and lymph node involvement in nasopharyngeal carcinoma. METHODS: This study was cross-sectional, that enrolled 126 samples diagnosed with nasopharyngeal carcinoma in Haji Adam Malik General Hospital, Medan, Indonesia which fulfilled the inclusion criteria. RESULTS: Based on this study, we found that the age peak incidence of nasopharyngeal carcinoma patients about a 41-60-year-old group (57.1%), dominated by men (71.4%). Through histopathological examination, non-keratinizing squamous cell carcinoma is the most predominant type (79.4%). We also found T3 is the most prevalent primary tumour size (32.5%) with prominent lymph node involvement N3 (45.2%), and stage IV (54.8%). Cyclooxygenase-2 overexpression is prevalent among nonkeratinizing squamous cell carcinoma (81.1%), T3 primary tumour size (41.1%), N3 node involvement (60.0%), and IV clinical stage (71.6%). In addition, we found a significant relationship between cyclooxygenase-2 expressions towards tumor size (p < 0.001) and lymph node involvement (p < 0.001) in nasopharyngeal carcinoma. CONCLUSION: It is proved that the overexpression of cyclooxygenase-2 will increase the susceptibility of nasopharyngeal carcinoma patients having advanced primary tumour size and lymph node involvement.

3.
Open Access Maced J Med Sci ; 6(6): 1101-1103, 2018 Jun 20.
Artículo en Inglés | MEDLINE | ID: mdl-29983811

RESUMEN

BACKGROUND: Pleomorphic adenoma is a salivary gland tumour and mostly found in the parotid gland and quite uncommon in the submandibular gland. Pleomorphic tumours are a mixed tumour (benign mixed tumour) consisted of epithelium, myoepithelium, and mesenchyme and made of a view component variation of it. CASE REPORT: We reported a fifty-three years old man with pleomorphic adenoma that has been complaining swelling on the left neck for the last twenty years and treated with surgical excision. Computed tomography of the neck showed soft tissue tumour in the left submandibular. CONCLUSIONS: The best management for pleomorphic adenoma is surgery, the tumour tissue must be removed as a whole because the remaining parts of a tumour can easily become recurrent or turn into a malignant tumour.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA